Sean Maduck - 15 May 2018 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Role
Officer
Signature
/s/ Joseph Douglas Lyon, as attorney-in-fact for Sean Maduck
Issuer symbol
CORT
Transactions as of
15 May 2018
Net transactions value
+$38,800
Form type
4
Filing time
02 Jun 2025, 20:57:58 UTC
Next filing
09 Jul 2021
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Maduck Sean Officer C/O CORCEPT THERAPEUTICS INCORPORATED, 101 REDWOOD SHORES PARKWAY, REDWOOD CITY /s/ Joseph Douglas Lyon, as attorney-in-fact for Sean Maduck 02 Jun 2025 0001698310

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CORT Common Stock Gift $0 -10,000 -12% $0.000000 75,622 15 May 2018 Direct F1
transaction CORT Common Stock Other $0 +10,000 +100% $0.000000 20,000 15 May 2018 See Footnote F2, F3
transaction CORT Common Stock Gift $0 -10,000 -13% $0.000000 65,622 13 Dec 2018 Direct F1
transaction CORT Common Stock Other $0 +10,000 +50% $0.000000 30,000 13 Dec 2018 See Footnote F2, F3
transaction CORT Common Stock Gift $0 -10,000 -15% $0.000000 55,622 13 Jul 2021 Direct F1
transaction CORT Common Stock Other $0 +10,000 +33% $0.000000 40,000 13 Jul 2021 See Footnote F2, F3
transaction CORT Common Stock Gift $0 -14,594 -26% $0.000000 41,028 19 Aug 2022 Direct F1
transaction CORT Common Stock Other $0 +14,594 +36% $0.000000 54,594 19 Aug 2022 See Footnote F2, F3
transaction CORT Common Stock Gift $0 -922 -2.2% $0.000000 40,106 01 Sep 2022 Direct F1
transaction CORT Common Stock Other $0 +922 +1.7% $0.000000 55,516 01 Sep 2022 See Footnote F2, F3
transaction CORT Common Stock Gift $0 -1,460 -3.6% $0.000000 38,646 01 Mar 2023 Direct F1
transaction CORT Common Stock Other $0 +1,460 +2.6% $0.000000 56,976 01 Mar 2023 See Footnote F2, F3
transaction CORT Common Stock Gift $0 -1,658 -4.3% $0.000000 36,988 01 Jun 2023 Direct F1
transaction CORT Common Stock Other $0 +1,658 +2.9% $0.000000 58,634 01 Jun 2023 See Footnote F2, F3
transaction CORT Common Stock Gift $0 -10,000 -27% $0.000000 26,988 17 Jul 2023 Direct F1
transaction CORT Common Stock Other $0 +10,000 +17% $0.000000 68,634 17 Jul 2023 See Footnote F2, F3
transaction CORT Common Stock Gift $0 -1,059 -3.9% $0.000000 25,929 01 Sep 2023 Direct F1
transaction CORT Common Stock Other $0 +1,059 +1.5% $0.000000 69,693 01 Sep 2023 See Footnote F2, F3
transaction CORT Common Stock Gift $0 -10,000 -39% $0.000000 15,929 19 Mar 2024 Direct F1
transaction CORT Common Stock Other $0 +10,000 +14% $0.000000 79,693 19 Mar 2024 See Footnote F2, F3
transaction CORT Common Stock Options Exercise $38,800 +10,000 +63% $3.88 25,929 29 May 2025 Direct F1
transaction CORT Common Stock Gift $0 -10,000 -39% $0.000000 15,929 29 May 2025 Direct F1
transaction CORT Common Stock Other $0 +10,000 +13% $0.000000 89,693 29 May 2025 See Footnote F2, F3
holding CORT Common Stock 10,000 15 May 2018 See Footnote F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CORT Stock option (right to buy) Options Exercise $0 -10,000 -100% $0.000000 0 29 May 2025 Common Stock 10,000 $3.88 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 458 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024, 265 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024 and 266 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.
F2 Transfer of shares without consideration to the Sean and Molly Maduck Living Trust.
F3 Represents the shares held by Sean and Molly Maduck Living Trust of which the Reporting Person is a co-trustee.
F4 Represents the shares held by Duckhill Capital, LLC of which the Reporting Person is President and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.
F5 Fully exercisable.

Remarks:

President, Corcept Endocrinology. The power of attorney under which this form was signed is on file with the Commission.